Champions Oncology Inc expected to post a loss of 17 cents a share - Earnings Preview
08/12/2023 21:03
* Champions Oncology Inc CSBR.OQ CSBR.O is expected
to show a
fall in quarterly revenue when it reports results for the
period ending July 31 2023
* The Baltimore Maryland-based company is expected to
report a
10.1% decrease in revenue to $12.844 million from $14.28 million
a year ago, according to the mean estimate from 3 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Champions Oncology Inc
is for
a loss of 17 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $8.75, above its last closing price of $4.97.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jul. 31 2023 -0.10 -0.10 -0.19 Missed -90
Apr. 30 2023 -0.12 -0.19 Missed -52
Jan. 31 2023 -0.06 -0.03 -0.18 Missed -414.3
Oct. 31 2022 -0.01 -0.01 0.00 Beat 100
Jul. 0.01 0.01 -0.02 Missed -300
31 2022
Apr. 30 2022 0.03 -0.03 Missed -220
Jan. 31 2022 0.02 0.03 0.05 Beat 100
Oct. 31 2021 0.01 0.01 0.02 Beat 300
This summary was machine generated December 8 at 21:02 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)